Advanced Portfolio Management’s ResMed RMD Stock Holding History

Advanced Portfolio Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-8,785	Closed	-$1.51M	–	69
2023 Q4	$1.51M	Buy	+8,785	New	+$1.35M	1.59%	24

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Advanced Portfolio Management's RMD Position: Q1 2024 in Review

Advanced Portfolio Management sold out of ResMed (RMD) in Q1 2024, closing a stake of 8,785 shares — an estimated $1.51M sold.

Advanced Portfolio Management first reported a position in RMD in Q4 2023 and held it in 1 quarter. The position peaked at $1.51M in Q4 2023. 718 funds tracked by Wall St. Rank hold RMD as of Q1 2024.

Advanced Portfolio Management reported no remaining ResMed position as of Q1 2024 after selling out during the quarter.
Advanced Portfolio Management sold 8,785 ResMed shares in Q1 2024, an estimated $1.51M.
Advanced Portfolio Management first reported a position in ResMed in Q4 2023 and held it in 1 quarter.
Advanced Portfolio Management's ResMed position peaked at $1.51M in Q4 2023.
718 funds tracked by Wall St. Rank held ResMed as of Q1 2024.

Based on Advanced Portfolio Management's 13F filing for Q1 2024, filed 15 May 2024.